A Case of Hereditary Angioedema Managed with Fresh Frozen Plasma

Read full text Summarise with VIRAT
Authors: Kamal Verma, Shubham Verma
Cited by: 0
References: 6

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Abstract Hereditary angioedema (HAE) is a rare autosomal dominant disorder due to deficiency or dysfunction of the complement 1 esterase inhibitor (C1-INH) and leading to bradykinin-mediated angioedema. It commonly affects the skin, gastrointestinal tract, and upper airway and may be life-threatening. Conventional therapies such as corticosteroids, antihistamines, and epinephrine are usually ineffective. [1,2] We report a case of HAE type I with recurrent exacerbations and progressive laryngeal edema causing respiratory distress, unresponsive to standard therapy. The patient was electively intubated for airway protection. Due to nonavailability of C1-INH concentrate and kallikrein inhibitors in India, fresh frozen plasma (FFP) was administered. The patient showed marked clinical improvement and was successfully extubated within 48 h. Steroids were tapered, and the patient was discharged in stable condition. This case highlights the importance of early diagnosis and the role of FFP as an effective alternative therapy in resource-limited settings.

Fields of Study & Subjects

Coagulation Bradykinin Polyphosphates and Angioedema Complement system in diseases Hemophilia Treatment and Research

Publication details

Journal / source
Sarvodaya International Journal of Medicine
Volume
2
Issue
1
Pages
40–42
Publication date
1 January 2026
Language
EN